Euclises Pharmaceuticals, Inc.
Pharmaceutical company · St. Louis, Missouri, United States
Euclises Pharmaceuticals, Inc. is a pharmaceutical company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $1.2 million sold in a notice filed in 2016.
Euclises Pharmaceuticals at a glance
What does Euclises Pharmaceuticals do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $1.2 million sold (2016).
Frequently asked questions about Euclises Pharmaceuticals
Where is Euclises Pharmaceuticals headquartered?
Euclises Pharmaceuticals, Inc. is headquartered in St. Louis, Missouri, United States.
What does Euclises Pharmaceuticals do?
Euclises Pharmaceuticals, Inc. is a pharmaceutical company.
When was Euclises Pharmaceuticals founded?
The earliest incorporation on record for Euclises Pharmaceuticals, Inc. is in 2011, according to public company registers.
Similar companies
- Immunophotonics, Inc.St. Louis, Missouri, United States
- Kypha Inc.St. Louis, Missouri, United States
- Indalo Therapeutics, Inc.St. Louis, Missouri, United States
- Aperta Biosciences, LLCSt. Louis, Missouri, United States
- Reliable Biopharmaceutical CorporationSt. Louis, Missouri, United States
- Par Health, Inc.St. Louis, Missouri, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences